Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Skin neoplasms malignant and unspecified
ADR ID BADD_A04053
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.03      Skin neoplasms malignant and unspecified
23      Skin and subcutaneous tissue disorders
23.08      Skin neoplasms malignant and unspecified
Description Not Available
MedDRA Code 10040900
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Not Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02106Tadalafil0.014541%
BADD_D02107Tafamidis0.000538%
BADD_D02150Temozolomide0.000112%
BADD_D02154Tenofovir0.004265%
BADD_D02165Teriflunomide0.002170%
BADD_D02192Thalidomide0.002532%
BADD_D02210Tiagabine--
BADD_D02211Tiagabine hydrochloride--
BADD_D02230Tizanidine--
BADD_D02231Tizanidine hydrochloride--
BADD_D02236Tofacitinib0.030091%
BADD_D02237Tofacitinib citrate--
BADD_D02241Tolcapone--
BADD_D02252Tositumomab--
BADD_D02257Trametinib0.000728%
BADD_D02322Ustekinumab--
BADD_D02325Valdecoxib--
BADD_D02331Valsartan0.000926%
BADD_D02342Vedolizumab--
BADD_D02344Vemurafenib0.012335%
BADD_D02345Venetoclax0.000336%
BADD_D02365Vismodegib0.008025%
BADD_D02367Voltaren--
BADD_D02369Voriconazole0.212011%
BADD_D02373Warfarin--
BADD_D02375Water--
BADD_D02392Zoledronic acid--
BADD_D02394Zolpidem0.000025%
BADD_D02407Upadacitinib0.006486%
BADD_D02412Octreotide--
The 6th Page    First    Pre   6 7    Next   Last    Total 7 Pages